Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, and Immunotherapy and Immune Responses.
Abstract 7424: Longitudinal and spatial heterogeneity of intra-tumoral TCR repertoires during immunotherapy in metastatic cancers
Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes
3D genomic mapping reveals multifocality of human pancreatic precancers
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers
Persistent mutation burden drives sustained anti-tumor immune responses
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
Genomic characterization of malignant progression in neoplastic pancreatic cysts
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
Genome-wide cell-free DNA fragmentation in patients with cancer
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer
High grade serous ovarian carcinomas originate in the fallopian tube
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
The genomic landscape of response to EGFR blockade in colorectal cancer
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
CRAVAT: cancer-related analysis of variants toolkit